Validation of claims‐based algorithms to identify patients with psoriasis
- 13 March 2021
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 30 (7) , 868-874
Abstract
Purpose: Accurately identifying patients with psoriasis (PsO) is crucial for generating real‐world evidence on PsO disease course and treatment utilization.Methods: We developed nine claims‐based algorithms for PsO using a combination of the International Classification of Diseases (ICD)‐9 codes, specialist visit, and medication dispensing using Medicare linked to electronic health records data (2013–2014) in two healthcare provider networks in Boston, Massachusetts. We calculated positive predictive value (PPV) and 95% confidence interval (CI) for each algorithm using the treating physician's diagnosis of PsO via chart review as the gold standard. Among the confirmed PsO cases, we assessed their PsO disease activity.Results: The nine claims‐based algorithms identified 990 unique patient records. Of those, 918 (92.7%) with adequate information were reviewed. The PPV of the algorithms ranged from 65.1 to 82.9%. An algorithm defined as ≥1 ICD‐9 diagnosis code for PsO and ≥1 prescription claim for topical vitamin D agents showed the highest PPV (82.9%). The PPV of the algorithm requiring ≥2 ICD‐9 diagnosis codes and ≥1 prescription claim for PsO treatment excluding topical steroids was 81.1% but higher (82.5%) when ≥1 diagnosis was from a dermatologist. Among 411 PsO patients with adequate information on PsO disease activity in EHRs, 1.5–5.8% had no disease activity, 31.3–36.8% mild, and 26.9–35.1% moderate‐to‐severe across the algorithms.Conclusions: Claims‐based algorithms based on a combination of PsO diagnosis codes and dispensing for PsO‐specific treatments had a moderate‐to‐high PPV. These algorithms can serve as a useful tool to identify patients with PsO in future real‐world data pharmacoepidemiologic studies.Keywords
Funding Information
- AbbVie
This publication has 18 references indexed in Scilit:
- Validity of Diagnostic Codes and Prevalence of Physician-Diagnosed Psoriasis and Psoriatic Arthritis in Southern Sweden – A Population-Based Register StudyPLOS ONE, 2014
- Psoriasis prevalence among adults in the United StatesJournal of the American Academy of Dermatology, 2014
- Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996–2009Pharmacoepidemiology and Drug Safety, 2013
- Validity of The Health Improvement Network (THIN) for the study of psoriasisBritish Journal of Dermatology, 2010
- Potential misclassification of patients with psoriasis in electronic databasesJournal of the American Academy of Dermatology, 2008
- Use of Health Care Databases in PharmacoepidemiologyBasic & Clinical Pharmacology & Toxicology, 2006
- Age, gender, quality of life and psychological distress in patients hospitalized with psoriasisBritish Journal of Dermatology, 2005
- Psoriasis of early and late onset: A clinical and epidemiologic study from SpainJournal of the American Academy of Dermatology, 2002
- Bimodality in Age of Onset of Psoriasis, in Both Patients and Their RelativesDermatology, 1993
- Psoriasis of early and late onset: Characterization of two types of psoriasis vulgarisJournal of the American Academy of Dermatology, 1985